Immune-related cholangitis induced by immune checkpoint inhibitors: a systematic review of clinical features and management

BACKGROUND & AIMS: Immune checkpoint inhibitors (ICIs) improve the survival of patients with advanced tumors. However, immune-related adverse events limit the use of ICIs. Although liver toxicity has been concerned gradually, little is known about bile duct injury associated with ICIs. Hence, th...

Descripción completa

Detalles Bibliográficos
Autores principales: Pi, Borui, Wang, Jin, Tong, Yifan, Yang, Qiao, Lv, Fangfang, Yu, Yunsong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams And Wilkins 2021
Materias:
Original Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734631/
https://www.ncbi.nlm.nih.gov/pubmed/34482313
http://dx.doi.org/10.1097/MEG.0000000000002280

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734631/
https://www.ncbi.nlm.nih.gov/pubmed/34482313
http://dx.doi.org/10.1097/MEG.0000000000002280

Ejemplares similares